In vitro activity of dimethylarsinic acid against human leukemia and multiple myeloma cell lines View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2003-03-26

AUTHORS

Hatice Duzkale, Iman Jilani, Nada Orsolic, Ralph A. Zingaro, Mirna Golemovic, Francis J. Giles, Hagop Kantarjian, Maher Albitar, Emil J. Freireich, Srdan Verstovsek

ABSTRACT

PurposeArsenic trioxide (As2O3), an inorganic arsenic compound, has recently been approved for the treatment of relapsed or refractory acute promyelocytic leukemia. However, systemic toxicity associated with As2O3 treatment remains a problem. Inorganic arsenic is detoxified in vivo by methylation reactions into organic arsenic compounds that are less toxic.Methods and resultsWe investigated the antiproliferative and cytotoxic activity of dimethylarsinic acid (DMAA), an organic arsenic derivative and major metabolic by-product of As2O3, against a panel of eight leukemia and multiple myeloma cell lines. As2O3 was tested in comparison. In clonogenic assay, the average concentration of DMAA that suppressed cell colony growth by 50% was 0.5–1 mM, while for As2O3 it was on average 1–2 μM. At those concentrations DMAA and As2O3 had significantly less effect on colony growth of normal progenitor cells. Cytotoxic doses of DMAA and As2O3 in 3-day trypan blue dye exclusion assay experiments were similar to doses effective in clonogenic assay. Assessment of apoptosis by annexin V assay revealed a high rate of apoptosis in all cell lines treated with DMAA and As2O3, but significantly less effect on normal progenitor cells. DMAA, unlike As2O3, had no effect on the maturation of leukemic cells.ConclusionsDMAA exerts differential antiproliferative and cytotoxic activity against leukemia and multiple myeloma cells, with no significant effect on normal progenitor cells. However, concentrations of DMAA needed to achieve such efficacy are up to 1000 times those of As2O3. Evaluation of novel organic arsenic that would combine the high efficacy of As2O3 and the low toxicity of DMAA is warranted. More... »

PAGES

427-432

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00280-003-0588-x

DOI

http://dx.doi.org/10.1007/s00280-003-0588-x

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1075282913

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/12736761


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cacodylic Acid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Death", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Division", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Screening Assays, Antitumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Herbicides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Multiple Myeloma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Cells, Cultured", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Special Medical Education Programs, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Special Medical Education Programs, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Duzkale", 
        "givenName": "Hatice", 
        "id": "sg:person.01262772611.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01262772611.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Laboratory Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Laboratory Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jilani", 
        "givenName": "Iman", 
        "id": "sg:person.01243100030.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01243100030.85"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, TX 77030, Houston, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, TX 77030, Houston, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Orsolic", 
        "givenName": "Nada", 
        "id": "sg:person.01206275256.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206275256.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Chemistry, Texas A&M University, College Station, Texas, USA", 
          "id": "http://www.grid.ac/institutes/grid.264756.4", 
          "name": [
            "Department of Chemistry, Texas A&M University, College Station, Texas, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zingaro", 
        "givenName": "Ralph A.", 
        "id": "sg:person.015176277633.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015176277633.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, TX 77030, Houston, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, TX 77030, Houston, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Golemovic", 
        "givenName": "Mirna", 
        "id": "sg:person.0670417703.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0670417703.84"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, TX 77030, Houston, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, TX 77030, Houston, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Giles", 
        "givenName": "Francis J.", 
        "id": "sg:person.011165370517.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011165370517.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, TX 77030, Houston, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, TX 77030, Houston, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kantarjian", 
        "givenName": "Hagop", 
        "id": "sg:person.07607502677.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07607502677.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Laboratory Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Laboratory Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Albitar", 
        "givenName": "Maher", 
        "id": "sg:person.01166330457.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01166330457.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Special Medical Education Programs, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Special Medical Education Programs, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Freireich", 
        "givenName": "Emil J.", 
        "id": "sg:person.01121770341.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01121770341.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, TX 77030, Houston, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, TX 77030, Houston, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Verstovsek", 
        "givenName": "Srdan", 
        "id": "sg:person.01363561206.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01363561206.49"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s002040050344", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011924248", 
          "https://doi.org/10.1007/s002040050344"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1385/ct:2:1:63", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022878666", 
          "https://doi.org/10.1385/ct:2:1:63"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s002040050544", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032114816", 
          "https://doi.org/10.1007/s002040050544"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s002040050454", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046718653", 
          "https://doi.org/10.1007/s002040050454"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00405933", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047887599", 
          "https://doi.org/10.1007/bf00405933"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s002040000134", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027962220", 
          "https://doi.org/10.1007/s002040000134"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01984946", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025703253", 
          "https://doi.org/10.1007/bf01984946"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2003-03-26", 
    "datePublishedReg": "2003-03-26", 
    "description": "PurposeArsenic trioxide (As2O3), an inorganic arsenic compound, has recently been approved for the treatment of relapsed or refractory acute promyelocytic leukemia. However, systemic toxicity associated with As2O3 treatment remains a problem. Inorganic arsenic is detoxified in vivo by methylation reactions into organic arsenic compounds that are less toxic.Methods and resultsWe investigated the antiproliferative and cytotoxic activity of dimethylarsinic acid (DMAA), an organic arsenic derivative and major metabolic by-product of As2O3, against a panel of eight leukemia and multiple myeloma cell lines. As2O3 was tested in comparison. In clonogenic assay, the average concentration of DMAA that suppressed cell colony growth by 50% was 0.5\u20131\u00a0mM, while for As2O3 it was on average 1\u20132\u00a0\u03bcM. At those concentrations DMAA and As2O3 had significantly less effect on colony growth of normal progenitor cells. Cytotoxic doses of DMAA and As2O3 in 3-day trypan blue dye exclusion assay experiments were similar to doses effective in clonogenic assay. Assessment of apoptosis by annexin V assay revealed a high rate of apoptosis in all cell lines treated with DMAA and As2O3, but significantly less effect on normal progenitor cells. DMAA, unlike As2O3, had no effect on the maturation of leukemic cells.ConclusionsDMAA exerts differential antiproliferative and cytotoxic activity against leukemia and multiple myeloma cells, with no significant effect on normal progenitor cells. However, concentrations of DMAA needed to achieve such efficacy are up to 1000 times those of As2O3. Evaluation of novel organic arsenic that would combine the high efficacy of As2O3 and the low toxicity of DMAA is warranted.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00280-003-0588-x", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1088364", 
        "issn": [
          "0344-5704", 
          "1432-0843"
        ], 
        "name": "Cancer Chemotherapy and Pharmacology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "51"
      }
    ], 
    "keywords": [
      "normal progenitor cells", 
      "multiple myeloma cell lines", 
      "myeloma cell lines", 
      "progenitor cells", 
      "clonogenic assay", 
      "cell lines", 
      "refractory acute promyelocytic leukemia", 
      "acute promyelocytic leukemia", 
      "multiple myeloma cells", 
      "trypan blue dye exclusion", 
      "cytotoxic activity", 
      "assessment of apoptosis", 
      "cell colony growth", 
      "promyelocytic leukemia", 
      "As2O3 treatment", 
      "leukemic cells", 
      "systemic toxicity", 
      "myeloma cells", 
      "leukemia", 
      "cytotoxic doses", 
      "high efficacy", 
      "such efficacy", 
      "dye exclusion", 
      "Annexin V", 
      "human leukemia", 
      "colony growth", 
      "concentration of DMA", 
      "less effect", 
      "high rate", 
      "dimethylarsinic acid", 
      "doses", 
      "efficacy", 
      "cells", 
      "treatment", 
      "apoptosis", 
      "toxicity", 
      "inorganic arsenic", 
      "assays", 
      "low toxicity", 
      "As2O3", 
      "activity", 
      "ResultsWe", 
      "significant effect", 
      "effect", 
      "vivo", 
      "inorganic arsenic compounds", 
      "arsenic compounds", 
      "maturation", 
      "exerts", 
      "acid", 
      "concentration", 
      "lines", 
      "assessment", 
      "methylation reactions", 
      "organic arsenic compounds", 
      "evaluation", 
      "organic arsenic", 
      "average concentration", 
      "rate", 
      "exclusion", 
      "panel", 
      "growth", 
      "trioxide", 
      "compounds", 
      "arsenic", 
      "time", 
      "comparison", 
      "reaction", 
      "method", 
      "products", 
      "problem", 
      "experiments"
    ], 
    "name": "In vitro activity of dimethylarsinic acid against human leukemia and multiple myeloma cell lines", 
    "pagination": "427-432", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1075282913"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00280-003-0588-x"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "12736761"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00280-003-0588-x", 
      "https://app.dimensions.ai/details/publication/pub.1075282913"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:23", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_371.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00280-003-0588-x"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00280-003-0588-x'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00280-003-0588-x'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00280-003-0588-x'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00280-003-0588-x'


 

This table displays all metadata directly associated to this object as RDF triples.

267 TRIPLES      21 PREDICATES      113 URIs      98 LITERALS      16 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00280-003-0588-x schema:about N00c7c2fdc49f4d6f997b66fdefa15416
2 N1101006d516f4cb6bb8cdc318ffa1dd8
3 N36a416167d8d4000b6a886d7eeea4e52
4 N38fd04387471458baf126fa294918294
5 N51f8db7b29944be69c4cc2af21391623
6 N5cba7bd0869f4ae7ae4550190a3bf93a
7 N73b4a906819e4e66ab90453d7ea0b8d9
8 Neca86e18bc1b41d681c476817ccd8338
9 Nf898a1ea98cf44c491908f7bd98a8c80
10 anzsrc-for:11
11 anzsrc-for:1102
12 schema:author Nbc648a875b914f95b38f7960c51a22c9
13 schema:citation sg:pub.10.1007/bf00405933
14 sg:pub.10.1007/bf01984946
15 sg:pub.10.1007/s002040000134
16 sg:pub.10.1007/s002040050344
17 sg:pub.10.1007/s002040050454
18 sg:pub.10.1007/s002040050544
19 sg:pub.10.1385/ct:2:1:63
20 schema:datePublished 2003-03-26
21 schema:datePublishedReg 2003-03-26
22 schema:description PurposeArsenic trioxide (As2O3), an inorganic arsenic compound, has recently been approved for the treatment of relapsed or refractory acute promyelocytic leukemia. However, systemic toxicity associated with As2O3 treatment remains a problem. Inorganic arsenic is detoxified in vivo by methylation reactions into organic arsenic compounds that are less toxic.Methods and resultsWe investigated the antiproliferative and cytotoxic activity of dimethylarsinic acid (DMAA), an organic arsenic derivative and major metabolic by-product of As2O3, against a panel of eight leukemia and multiple myeloma cell lines. As2O3 was tested in comparison. In clonogenic assay, the average concentration of DMAA that suppressed cell colony growth by 50% was 0.5–1 mM, while for As2O3 it was on average 1–2 μM. At those concentrations DMAA and As2O3 had significantly less effect on colony growth of normal progenitor cells. Cytotoxic doses of DMAA and As2O3 in 3-day trypan blue dye exclusion assay experiments were similar to doses effective in clonogenic assay. Assessment of apoptosis by annexin V assay revealed a high rate of apoptosis in all cell lines treated with DMAA and As2O3, but significantly less effect on normal progenitor cells. DMAA, unlike As2O3, had no effect on the maturation of leukemic cells.ConclusionsDMAA exerts differential antiproliferative and cytotoxic activity against leukemia and multiple myeloma cells, with no significant effect on normal progenitor cells. However, concentrations of DMAA needed to achieve such efficacy are up to 1000 times those of As2O3. Evaluation of novel organic arsenic that would combine the high efficacy of As2O3 and the low toxicity of DMAA is warranted.
23 schema:genre article
24 schema:isAccessibleForFree false
25 schema:isPartOf N71d927170d2a4d58a61bc3ff0a395ee2
26 N9f1b318342af4df295d069fdb33e3c5e
27 sg:journal.1088364
28 schema:keywords Annexin V
29 As2O3
30 As2O3 treatment
31 ResultsWe
32 acid
33 activity
34 acute promyelocytic leukemia
35 apoptosis
36 arsenic
37 arsenic compounds
38 assays
39 assessment
40 assessment of apoptosis
41 average concentration
42 cell colony growth
43 cell lines
44 cells
45 clonogenic assay
46 colony growth
47 comparison
48 compounds
49 concentration
50 concentration of DMA
51 cytotoxic activity
52 cytotoxic doses
53 dimethylarsinic acid
54 doses
55 dye exclusion
56 effect
57 efficacy
58 evaluation
59 exclusion
60 exerts
61 experiments
62 growth
63 high efficacy
64 high rate
65 human leukemia
66 inorganic arsenic
67 inorganic arsenic compounds
68 less effect
69 leukemia
70 leukemic cells
71 lines
72 low toxicity
73 maturation
74 method
75 methylation reactions
76 multiple myeloma cell lines
77 multiple myeloma cells
78 myeloma cell lines
79 myeloma cells
80 normal progenitor cells
81 organic arsenic
82 organic arsenic compounds
83 panel
84 problem
85 products
86 progenitor cells
87 promyelocytic leukemia
88 rate
89 reaction
90 refractory acute promyelocytic leukemia
91 significant effect
92 such efficacy
93 systemic toxicity
94 time
95 toxicity
96 treatment
97 trioxide
98 trypan blue dye exclusion
99 vivo
100 schema:name In vitro activity of dimethylarsinic acid against human leukemia and multiple myeloma cell lines
101 schema:pagination 427-432
102 schema:productId N18336bf066da43d3a119c5a2092c72b5
103 Nc0146e9510bd408c829b8bcdaa7761a4
104 Nea6c682ea16944aab56defccc023e579
105 schema:sameAs https://app.dimensions.ai/details/publication/pub.1075282913
106 https://doi.org/10.1007/s00280-003-0588-x
107 schema:sdDatePublished 2022-12-01T06:23
108 schema:sdLicense https://scigraph.springernature.com/explorer/license/
109 schema:sdPublisher N756325eda8054793ba7e5a693fb0a0b0
110 schema:url https://doi.org/10.1007/s00280-003-0588-x
111 sgo:license sg:explorer/license/
112 sgo:sdDataset articles
113 rdf:type schema:ScholarlyArticle
114 N00c7c2fdc49f4d6f997b66fdefa15416 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Cacodylic Acid
116 rdf:type schema:DefinedTerm
117 N03d0c23ffff8442ba756e6efebc0e6e6 rdf:first sg:person.01363561206.49
118 rdf:rest rdf:nil
119 N1101006d516f4cb6bb8cdc318ffa1dd8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Cell Death
121 rdf:type schema:DefinedTerm
122 N18336bf066da43d3a119c5a2092c72b5 schema:name dimensions_id
123 schema:value pub.1075282913
124 rdf:type schema:PropertyValue
125 N346abddf910e42f798c1c2e9d31e430f rdf:first sg:person.01206275256.18
126 rdf:rest N6088fa3fa8074b26b8915bf9c68af36b
127 N36a416167d8d4000b6a886d7eeea4e52 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Cell Division
129 rdf:type schema:DefinedTerm
130 N38fd04387471458baf126fa294918294 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Leukemia
132 rdf:type schema:DefinedTerm
133 N51f8db7b29944be69c4cc2af21391623 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Humans
135 rdf:type schema:DefinedTerm
136 N51fd0ad974d04005822eca81730c2d90 rdf:first sg:person.01243100030.85
137 rdf:rest N346abddf910e42f798c1c2e9d31e430f
138 N5cba7bd0869f4ae7ae4550190a3bf93a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Herbicides
140 rdf:type schema:DefinedTerm
141 N6088fa3fa8074b26b8915bf9c68af36b rdf:first sg:person.015176277633.59
142 rdf:rest Ne4f8279ccb884a49b060535580516b5e
143 N6c142c2a5991491d9a16457f94ec8b19 rdf:first sg:person.011165370517.24
144 rdf:rest Nae6e87779c0f4c97bb47695e17c93a5e
145 N71d927170d2a4d58a61bc3ff0a395ee2 schema:volumeNumber 51
146 rdf:type schema:PublicationVolume
147 N73b4a906819e4e66ab90453d7ea0b8d9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Multiple Myeloma
149 rdf:type schema:DefinedTerm
150 N756325eda8054793ba7e5a693fb0a0b0 schema:name Springer Nature - SN SciGraph project
151 rdf:type schema:Organization
152 N81282e496a5041828a1913bfff1d58da rdf:first sg:person.01121770341.39
153 rdf:rest N03d0c23ffff8442ba756e6efebc0e6e6
154 N88a4cee2cb354bef9192e6b6ec428203 rdf:first sg:person.01166330457.80
155 rdf:rest N81282e496a5041828a1913bfff1d58da
156 N9f1b318342af4df295d069fdb33e3c5e schema:issueNumber 5
157 rdf:type schema:PublicationIssue
158 Nae6e87779c0f4c97bb47695e17c93a5e rdf:first sg:person.07607502677.73
159 rdf:rest N88a4cee2cb354bef9192e6b6ec428203
160 Nbc648a875b914f95b38f7960c51a22c9 rdf:first sg:person.01262772611.56
161 rdf:rest N51fd0ad974d04005822eca81730c2d90
162 Nc0146e9510bd408c829b8bcdaa7761a4 schema:name doi
163 schema:value 10.1007/s00280-003-0588-x
164 rdf:type schema:PropertyValue
165 Ne4f8279ccb884a49b060535580516b5e rdf:first sg:person.0670417703.84
166 rdf:rest N6c142c2a5991491d9a16457f94ec8b19
167 Nea6c682ea16944aab56defccc023e579 schema:name pubmed_id
168 schema:value 12736761
169 rdf:type schema:PropertyValue
170 Neca86e18bc1b41d681c476817ccd8338 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Tumor Cells, Cultured
172 rdf:type schema:DefinedTerm
173 Nf898a1ea98cf44c491908f7bd98a8c80 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Drug Screening Assays, Antitumor
175 rdf:type schema:DefinedTerm
176 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
177 schema:name Medical and Health Sciences
178 rdf:type schema:DefinedTerm
179 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
180 schema:name Cardiorespiratory Medicine and Haematology
181 rdf:type schema:DefinedTerm
182 sg:journal.1088364 schema:issn 0344-5704
183 1432-0843
184 schema:name Cancer Chemotherapy and Pharmacology
185 schema:publisher Springer Nature
186 rdf:type schema:Periodical
187 sg:person.011165370517.24 schema:affiliation grid-institutes:grid.240145.6
188 schema:familyName Giles
189 schema:givenName Francis J.
190 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011165370517.24
191 rdf:type schema:Person
192 sg:person.01121770341.39 schema:affiliation grid-institutes:grid.240145.6
193 schema:familyName Freireich
194 schema:givenName Emil J.
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01121770341.39
196 rdf:type schema:Person
197 sg:person.01166330457.80 schema:affiliation grid-institutes:grid.240145.6
198 schema:familyName Albitar
199 schema:givenName Maher
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01166330457.80
201 rdf:type schema:Person
202 sg:person.01206275256.18 schema:affiliation grid-institutes:grid.240145.6
203 schema:familyName Orsolic
204 schema:givenName Nada
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206275256.18
206 rdf:type schema:Person
207 sg:person.01243100030.85 schema:affiliation grid-institutes:grid.240145.6
208 schema:familyName Jilani
209 schema:givenName Iman
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01243100030.85
211 rdf:type schema:Person
212 sg:person.01262772611.56 schema:affiliation grid-institutes:grid.240145.6
213 schema:familyName Duzkale
214 schema:givenName Hatice
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01262772611.56
216 rdf:type schema:Person
217 sg:person.01363561206.49 schema:affiliation grid-institutes:grid.240145.6
218 schema:familyName Verstovsek
219 schema:givenName Srdan
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01363561206.49
221 rdf:type schema:Person
222 sg:person.015176277633.59 schema:affiliation grid-institutes:grid.264756.4
223 schema:familyName Zingaro
224 schema:givenName Ralph A.
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015176277633.59
226 rdf:type schema:Person
227 sg:person.0670417703.84 schema:affiliation grid-institutes:grid.240145.6
228 schema:familyName Golemovic
229 schema:givenName Mirna
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0670417703.84
231 rdf:type schema:Person
232 sg:person.07607502677.73 schema:affiliation grid-institutes:grid.240145.6
233 schema:familyName Kantarjian
234 schema:givenName Hagop
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07607502677.73
236 rdf:type schema:Person
237 sg:pub.10.1007/bf00405933 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047887599
238 https://doi.org/10.1007/bf00405933
239 rdf:type schema:CreativeWork
240 sg:pub.10.1007/bf01984946 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025703253
241 https://doi.org/10.1007/bf01984946
242 rdf:type schema:CreativeWork
243 sg:pub.10.1007/s002040000134 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027962220
244 https://doi.org/10.1007/s002040000134
245 rdf:type schema:CreativeWork
246 sg:pub.10.1007/s002040050344 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011924248
247 https://doi.org/10.1007/s002040050344
248 rdf:type schema:CreativeWork
249 sg:pub.10.1007/s002040050454 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046718653
250 https://doi.org/10.1007/s002040050454
251 rdf:type schema:CreativeWork
252 sg:pub.10.1007/s002040050544 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032114816
253 https://doi.org/10.1007/s002040050544
254 rdf:type schema:CreativeWork
255 sg:pub.10.1385/ct:2:1:63 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022878666
256 https://doi.org/10.1385/ct:2:1:63
257 rdf:type schema:CreativeWork
258 grid-institutes:grid.240145.6 schema:alternateName Department of Laboratory Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
259 Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, TX 77030, Houston, USA
260 Department of Special Medical Education Programs, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
261 schema:name Department of Laboratory Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
262 Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, TX 77030, Houston, USA
263 Department of Special Medical Education Programs, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
264 rdf:type schema:Organization
265 grid-institutes:grid.264756.4 schema:alternateName Department of Chemistry, Texas A&M University, College Station, Texas, USA
266 schema:name Department of Chemistry, Texas A&M University, College Station, Texas, USA
267 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...